Updates

Essentra - Acquires Clondalkin for US$455m

December 2014

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Essentra, which makes small components from plastic, fibre and foam, has announced the US$455m (£284m) acquisition of Clondalkin, a leading global provider of speciality packaging for the pharmaceutical and health care industries, part funded by a placing of new shares (10% of the share capital), which raised £169m.Clondalkin, which operates 24 facilities in North America and Europe, marks the second major foray into the growing healthcare segment following the £160m purchase of Contego in 2013. For the year ended 31 December, Clondalkin generated revenue of US$429m, EBITDA of US$55.5m and operating profit of US$37.2m, while synergies will be at least US$16m in 2016.Earlier, Essentra announced a strong ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Mears

Greene King

Essentra (December 2023)

Essentra - New acquisition for just 5.3x EBITDA post synergies (November 2023)

Essentra - £5m reduction in costs (October 2023)

Essentra - Huge dividend growth expected from FY’24 (July 2023)

Essentra - Cluster buying by directors (May 2023)

Essentra (March 2023)

Essentra - Outperforms early in a new cycle (January 2023)

Essentra (December 2022)

Essentra - Announces sale of filters; special dividend planned (November 2022)

Essentra (October 2022)

Essentra - Disposal of Packaging division (August 2022)

Essentra (July 2022)

Essentra - Strong start to 2022 (May 2022)

Essentra - Trading update drives chart breakout (February 2022)

Essentra - Industrial components and healthcare packaging firm to double eps by FY’23 (January 2022)

Essentra - Components and healthcare packaging firm on cusp of dramatic turnaround (December 2021)

Essentra (September 2015)

Essentra - Shares break through £10 (April 2015)

Essentra - New strategy to be unveiled in November (October 2014)

Essentra - Further acquisitions expected (April 2014)

Essentra - £200m borrowing facility available for potential acquisitions (December 2013)

Essentra (September 2013)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X